Activation of regulatory T cells instigates functional down-regulation of cytotoxic T lymphocytes in human breast cancer

Immunologic Research

Volumn 51, Issue 1, 2011, Pages 71-79

  Li, Chao Hsu ^a   Kuo, Wen Hong ^b   Chang, Wen Chun ^b   Huang, Su Cheng ^b   Chang, King Jen ^b,c   Sheu, Bor Ching ^b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHENG CHING GENERAL HOSPITAL   (Taiwan)

Author keywords

Breast cancer; FOXP3; Granzyme B; Perforin; Regulatory T cells

Indexed keywords

GAMMA INTERFERON; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; GRANZYME B; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; PERFORIN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER TISSUE; CASE CONTROL STUDY; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; IN VITRO STUDY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; UPREGULATION;

BREAST NEOPLASMS; CD8-POSITIVE T-LYMPHOCYTES; DOWN-REGULATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANZYMES; HUMANS; LYMPHOCYTE ACTIVATION; NEOPLASM PROTEINS; NEOPLASM STAGING; PERFORIN; RETROSPECTIVE STUDIES; T-LYMPHOCYTES, REGULATORY; TH1 CELLS;

EID: 80053565885     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-011-8242-x     Document Type: Article

References (40)

1. H Jonuleit E Schmitt M Stassen A Tuettenberg J Knop AH Enk 2001 Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood J Exp Med 193 1285 1294 11390435 10.1084/jem.193.11.1285 1:CAS:528:DC%2BD3MXktFyiurs%3D (Pubitemid 32524778)
2. LJ Standish ES Sweet J Novack CA Wenner C Bridge A Nelson M Martzen C Torkelson 2008 Breast cancer and the immune system J Soc Integr Oncol 6 158 168 19134448
3. L Strauss C Bergmann M Szczepanski W Gooding JT Johnson TL Whiteside 2007 A unique subset of CD4+CD25 high Foxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment Clin Cancer Res 13 4345 4354 17671115 10.1158/1078-0432.CCR-07- 0472 1:CAS:528:DC%2BD2sXotlGqsLg%3D (Pubitemid 47219698)
4. K Kretschmer I Apostolou E Jaeckel K Khazaie H von Boehmer 2006 Making regulatory T cells with defined antigen specificity: role in autoimmunity and cancer Immunol Rev 212 163 169 16903913 10.1111/j.0105-2896.2006.00411.x 1:CAS:528:DC%2BD28XpvFegt7g%3D (Pubitemid 44116707)
5. Y Belkaid 2007 Regulatory T cells and infection: a dangerous necessity Nat Rev Immunol 7 875 888 17948021 10.1038/nri2189 1:CAS:528:DC%2BD2sXht1WgsL7I (Pubitemid 350006238)
6. A Gallimore AK Simon 2008 Positive and negative influences of regulatory T cells on tumour immunity Oncogene 27 5886 5893 18836469 10.1038/onc.2008.269 1:CAS:528:DC%2BD1cXhtF2msbbL
7. DA Vignali LW Collison CJ Workman 2008 How regulatory T cells work Nat Rev Immunol 8 523 532 18566595 10.1038/nri2343 1:CAS:528:DC%2BD1cXns1ehs7g%3D
8. X Cao SF Cai TA Fehniger J Song LI Collins DR Piwnica-Worms TJ Ley 2007 Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance Immunity 27 635 646 17919943 10.1016/j.immuni.2007.08.014 1:CAS:528:DC%2BD2sXht1ygurzJ (Pubitemid 47628832)
9. SA Siddiqui X Frigola S Bonne-Annee M Mercader SM Kuntz AE Krambeck S Sengupta H Dong JC Cheville CM Lohse, et al. 2007 Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma Clin Cancer Res 13 2075 2081 17404089 10.1158/1078-0432.CCR-06-2139 1:CAS:528:DC%2BD2sXjs12rt74%3D (Pubitemid 46649875)
10. E Sato SH Olson J Ahn B Bundy H Nishikawa F Qian AA Jungbluth D Frosina S Gnjatic C Ambrosone, et al. 2005 Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer Proc Natl Acad Sci USA 102 18538 18543 16344461 10.1073/pnas.0509182102 1:CAS:528:DC%2BD28Xpt1Om (Pubitemid 43011261)
11. ES Jordanova A Gorter O Ayachi F Prins LG Durrant GG Kenter SH van der Burg GJ Fleuren 2008 Human leukocyte antigen class I, MHC class I chain-related molecule A and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients? Clin Cancer Res 14 2028 2035 18381941 10.1158/1078-0432.CCR-07-4554 1:CAS:528:DC%2BD1cXkt1akurs%3D (Pubitemid 351551112)
12. GJ Bates SB Fox C Han RD Leek JF Garcia AL Harris AH Banham 2006 Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse J Clin Oncol 24 5373 5380 17135638 10.1200/JCO.2006.05.9584 (Pubitemid 46623168)
13. M Viguier F Lemaitre O Verola MS Cho G Gorochov L Dubertret H Bachelez P Kourilsky L Ferradini 2004 Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells J Immunol 173 1444 1453 15240741 1:CAS:528:DC%2BD2cXlsVGhs70%3D (Pubitemid 38924326)
14. P DeLong RG Carroll AC Henry T Tanaka S Ahmad MS Leibowitz DH Sterman CH June SM Albelda RH Vonderheide 2005 Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma Cancer Biol Ther 4 342 346 15846066 10.4161/cbt.4.3.1644 1:CAS:528:DC%2BD28XjvF2jsg%3D%3D (Pubitemid 41351297)
15. BC Sheu SH Chiou HH Lin SN Chow SC Huang HN Ho SM Hsu 2005 Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma Cancer Res 65 2921 2929 15805295 10.1158/0008-5472.CAN-04-2108 1:CAS:528:DC%2BD2MXjtVeqt7g%3D (Pubitemid 40490097)
16. BC Sheu SM Hsu HN Ho RH Lin PL Torng SC Huang 1999 Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma Cancer 86 1537 1543 10526283 10.1002/(SICI)1097- 0142(19991015)86:8<1537::AID-CNCR21>3.0.CO;2-D 1:STN:280: DC%2BD3c%2FhtVSjtg%3D%3D (Pubitemid 29489788)
17. BC Sheu RH Lin HC Lien HN Ho SM Hsu SC Huang 2001 Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer J Immunol 167 2972 2978 11509647 1:CAS:528:DC%2BD3MXmtlSju7o%3D
18. BC Sheu WC Chang CY Cheng HH Lin DY Chang SC Huang 2008 Cytokine regulation networks in the cancer microenvironment Front Biosci 13 6255 6268 18508658 10.2741/3152 1:CAS:528:DC%2BD1cXnsVOitrw%3D
19. BC Sheu SM Hsu HN Ho HC Lien SC Huang RH Lin 2001 A novel role of metalloproteinase in cancer-mediated immunosuppression Cancer Res 61 237 242 11196168 1:CAS:528:DC%2BD3MXlsl2kuw%3D%3D
20. UK Liyanage TT Moore HG Joo Y Tanaka V Herrmann G Doherty JA Drebin SM Strasberg TJ Eberlein PS Goedegebuure, et al. 2002 Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma J Immunol 169 2756 2761 12193750 1:CAS:528:DC%2BD38XmsF2ns7k%3D (Pubitemid 34921025)
21. S Hori T Nomura S Sakaguchi 2003 Control of regulatory T cell development by the transcription factor Foxp3 Science 299 1057 1061 12522256 10.1126/science.1079490 1:CAS:528:DC%2BD3sXhtFarsbw%3D (Pubitemid 36222930)
22. J Huehn K Siegmund JC Lehmann C Siewert U Haubold M Feuerer GF Debes J Lauber O Frey GK Przybylski, et al. 2004 Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells J Exp Med 199 303 313 14757740 10.1084/jem.20031562 1:CAS:528:DC%2BD2cXhtVCitL8%3D (Pubitemid 38252043)
23. H Yagi T Nomura K Nakamura S Yamazaki T Kitawaki S Hori M Maeda M Onodera T Uchiyama S Fujii, et al. 2004 Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells Int Immunol 16 1643 1656 15466453 10.1093/intimm/dxh165 1:CAS:528:DC%2BD2cXos1WqtbY%3D (Pubitemid 39480783)
24. A Kosmaczewska L Ciszak S Potoczek I Frydecka 2008 The significance of Treg cells in defective tumor immunity Arch Immunol Ther Exp (Warsz) 56 181 191 10.1007/s00005-008-0018-1 1:CAS:528:DC%2BD1cXovFKqsr0%3D
25. DC Gondek LF Lu SA Quezada S Sakaguchi RJ Noelle 2005 Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism J Immunol 174 1783 1786 15699103 1:CAS:528:DC%2BD2MXhtV2ku7w%3D (Pubitemid 40223916)
26. WJ Grossman JW Verbsky W Barchet M Colonna JP Atkinson TJ Ley 2004 Human T regulatory cells can use the perforin pathway to cause autologous target cell death Immunity 21 589 601 15485635 10.1016/j.immuni.2004.09.002 1:CAS:528:DC%2BD2cXpvVygtLk%3D (Pubitemid 39370513)
27. MJ Smyth KY Thia SE Street D MacGregor DI Godfrey JA Trapani 2000 Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma J Exp Med 192 755 760 10974040 10.1084/jem.192.5.755 1:CAS:528:DC%2BD3cXmtlegtrg%3D
28. L Chavez-Galan MC Arenas-Del Angel E Zenteno R Chavez R Lascurain 2009 Cell death mechanisms induced by cytotoxic lymphocytes Cell Mol Immunol 6 15 25 19254476 10.1038/cmi.2009.3 1:CAS:528:DC%2BD1MXktFGksrs%3D
29. JA Trapani MJ Smyth 2002 Functional significance of the perforin/granzyme cell death pathway Nat Rev Immunol 2 735 747 12360212 10.1038/nri911 1:CAS:528:DC%2BD38XnsVGqsbk%3D (Pubitemid 37328714)
30. JP Medema J de Jong LT Peltenburg EM Verdegaal A Gorter SA Bres KL Franken M Hahne JP Albar CJ Melief, et al. 2001 Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors Proc Natl Acad Sci USA 98 11515 11520 11562487 10.1073/pnas.201398198 1:CAS:528: DC%2BD3MXnt12jsr8%3D (Pubitemid 32928760)
31. ME van den Broek D Kagi F Ossendorp R Toes S Vamvakas WK Lutz CJ Melief RM Zinkernagel H Hengartner 1996 Decreased tumor surveillance in perforin-deficient mice J Exp Med 184 1781 1790 8920866 10.1084/jem.184.5.1781 (Pubitemid 26404469)
32. SE Street N Zerafa M Iezzi JA Westwood J Stagg P Musiani MJ Smyth 2007 Host perforin reduces tumor number but does not increase survival in oncogene-driven mammary adenocarcinoma Cancer Res 67 5454 5460 17545627 10.1158/0008-5472.CAN-06-4084 1:CAS:528:DC%2BD2sXmtVaitLo%3D (Pubitemid 46997286)
33. MJ Waldner S Wirtz C Becker D Seidel I Tubbe K Cappel PS Hahnel PR Galle M Schuler MF Neurath 2010 Perforin deficiency attenuates inflammation and tumor growth in colitis-associated cancer Inflamm Bowel Dis 16 559 567 19785028
34. J Chia KP Yeo JC Whisstock MA Dunstone JA Trapani I Voskoboinik 2009 Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity, delayed FHL, and a predisposition to cancer Proc Natl Acad Sci USA 106 9809 9814 19487666 10.1073/pnas.0903815106 1:CAS:528:DC%2BD1MXotFGjs7s%3D
35. S Radoja M Saio D Schaer M Koneru S Vukmanovic AB Frey 2001 CD8(+) tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis J Immunol 167 5042 5051 11673513 1:CAS:528:DC%2BD3MXotVWjsrg%3D (Pubitemid 33009737)
36. ME Dudley JR Wunderlich PF Robbins JC Yang P Hwu DJ Schwartzentruber SL Topalian R Sherry NP Restifo AM Hubicki, et al. 2002 Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes Science 298 850 854 12242449 10.1126/science.1076514 1:CAS:528: DC%2BD38XotFSntbY%3D (Pubitemid 35231542)
37. ME Dudley JR Wunderlich JC Yang RM Sherry SL Topalian NP Restifo RE Royal U Kammula DE White SA Mavroukakis, et al. 2005 Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma J Clin Oncol 23 2346 2357 15800326 10.1200/JCO.2005.00.240 1:CAS:528:DC%2BD2MXjsVyhsrs%3D (Pubitemid 46218728)
38. JA Gonzalo T Delaney J Corcoran A Goodearl JC Gutierrez-Ramos AJ Coyle 2001 Cutting edge: the related molecules CD28 and inducible costimulator deliver both unique and complementary signals required for optimal T cell activation J Immunol 166 1 5 11123268 1:CAS:528:DC%2BD3MXis1ahtg%3D%3D (Pubitemid 32038408)
39. C Demanet J Brissinck J De Jonge K Thielemans 1996 Bispecific antibody-mediated immunotherapy of the BCL1 lymphoma: increased efficacy with multiple injections and CD28-induced costimulation Blood 87 4390 4398 8639800 1:CAS:528:DyaK28XivFGhurc%3D (Pubitemid 26152280)
40. CT Viehl TT Moore UK Liyanage DM Frey JP Ehlers TJ Eberlein PS Goedegebuure DC Linehan 2006 Depletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice Ann Surg Oncol 13 1252 1258 16952047 10.1245/s10434-006-9015-y (Pubitemid 44440427)